Azione NTII NEUROBIOLOGICAL TECHNOLOGIES, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Neurobiological Technologies, Inc.

Azioni

NTII

US64124W3043

Tempo differito OTC Markets
Altri mercati azionari
 19:42:05 06/06/2024 		Variaz. 5gg Var. 1 gen.
0,0001 USD +9.900,00% Grafico intraday di Neurobiological Technologies, Inc. -.--% +9.900,00%

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Neurobiological Technologies Inc. Announces Extraordinary Dividend, Payable on December 27, 2012
NEUROBIO TECH : Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share
NEUROBIO TECH : Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and Dissolution
NEUROBIO TECH : Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market
NEUROBIO TECH : Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification
NEUROBIO TECH : Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Children's Medical Center
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Suspension of Viprinex Development
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
NEUROBIOLO TCHNLGS : Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results
NEUROBIOLO TCHNLGS : Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10
NEUROBIOLO TCHNLGS : Neurobiological Technologies Sets Date for First Quarter Financial Results
NEUROBIOLO TCHNLGS : Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine
NEUROBIOLO TCHNLGS : Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
NEUROBIOLO TCHNLGS : Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione NTII
  4. Notizie Neurobiological Technologies, Inc.
  5. Altre lingue